HeartBeam partners with AccurKardia to enhance cardiac care
The partnership will focus on integrating AccurKardia's ECG analysis software with HeartBeam's devices.
Therapy Area
Synthetic hormones and the future of contraception
Epiminder’s implantable EEG system for epilepsy receives FDA authorisation
Vivasure wins CE mark for bioresorbable PerQseal Elite device
Novocure’s device for metastatic NSCLC treatment gains CE Mark
ARUP announces blood test to identify Alzheimer’s pathology
Pearsanta to begin study of endometriosis test with IRB approval
Cadwell invests in Australian company Seer Medical
